FDA labeling governs what is prescribed for which use
Months 3, 5, 7: Technical progress reports detailing technical progress made, tasks accomplished, major risks/mitigations, a technical plan for the remainder of Phase II (while this will normally report progress against the plan detailed in the proposal or presented at the Kickoff briefing, it is understood that scientific discoveries, competition, and regulatory changes may all have impacts on the planned work and DARPA must be made aware of any revisions that result), planned activities, trip summaries, and any potential issues or problem areas that require the attention of the DARPA PM
More research is therefore needed to better understand the safety and benefit GLP-1s offer to children and adolescents and to better understand their place in the broader continuum of weight management.
doi: 10.1113/JP276488 110 DalbramEBasseALZierathJRTreebakJT
BPC-157 to accelerate tissue repair
The drug is a once-a-week injection that combines two hormones, GLP-1 and GIP, which work in combination to stimulate insulin secretion and reduce appetite
